Text Size
2 studies found for:    "TARP syndrome"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Specific Antigens
Interventions: Drug: TARP 29-35 Peptide (Native Peptide);   Drug: TARP 29-37-9V Peptide Epitope Enchanced Peptide
2 Active, not recruiting PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Condition: Prostate Cancer
Intervention: Biological: Peptide Vaccine
To Top

† Indicates status has not been verified in more than two years